By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Dictionary
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Dictionary
    • Browse A–Z
    • About the Project
    • Contribute a Term
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Rethinking Smoking Cessation Requirements in Lung Cancer Surgery

Rethinking Smoking Cessation Requirements in Lung Cancer Surgery

GMJ
Last updated: 21/06/2026 03:17
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Medical illustration showing lung surgery outcomes comparison between smoking and non-smoking patients
New research from University of Cincinnati shows lung cancer patients who continue smoking before surgery have higher pulmonary complications but similar short-term mortality rates to those who quit. The findings may influence surgical decision-making for patients unable to stop smoking. — Photo by Aakash Dhage on Unsplash (Unsplash License)
SHARE
1 min read|130 words

A new study from the University of Cincinnati College of Medicine is prompting clinicians to reconsider surgical policies for lung cancer patients unable to quit smoking before their procedure. Researchers examined outcomes for patients undergoing surgical resection, comparing those who continued smoking with those who had successfully quit. The findings reveal a nuanced clinical picture: while current smokers experienced significantly higher rates of pulmonary complications—including pneumonia, prolonged air leaks, and respiratory failure—short-term mortality rates remained statistically similar between the two groups. This discovery challenges the assumption that continued smoking should automatically disqualify patients from potentially life-saving surgery. The research suggests that smoking status alone may not warrant delaying surgical intervention, though pulmonary complication risks warrant enhanced perioperative monitoring and management strategies. Read the full article on GMJ Newsroom.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Continued smoking before lung cancer surgery increases pulmonary complications but not short-term mortality →

Related reference
  • Lung Cancer · Condition
  • Pneumonia · Condition
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments

A qualitative study in Ethiopia reveals that health workers and patients view…

Sitafloxacin monotherapy matches doxycycline-rifampicin for brucellosis treatment in landmark trial

A multicenter randomized trial in The Lancet Regional Health – Western Pacific…

Ultra-processed foods linked to higher kidney cancer risk in large US study

A prospective analysis of over 300,000 US adults found that higher consumption…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical illustration showing multiple myeloma cells and treatment timeline concepts

Three Clinical Practice Changes Coming to Multiple Myeloma Care

By
Prof. Giorgi Pkhakadze
01/07/2026
Medical professional reviewing gene therapy cost analysis and payment models on computer screen

$2 Million Barrier: Gene Therapy Costs Expose Healthcare Financing Crisis

By
Prof. Giorgi Pkhakadze
19/07/2026

EBOLA OUTBREAK – DRC/UGANDA CROSS-BORDER TRANSMISSION WITH WHO PHEIC DECLARATION

By
Prof. Giorgi Pkhakadze
31/05/2026
Medical illustration showing melanoma cells and biomarker analysis for prognosis prediction

6,000+ Annual Melanoma Cases Demand Better Predictive Tools, New Research Shows

By
Prof. Giorgi Pkhakadze
13/07/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?